IP Library Granted Patent US 10,111,779
Granted Patent B2
US 10,111,779 · App. 15/280,174 · Granted Oct 30, 2018

Device and method for laser assisted deep sclerectomy

Inventors: Joshua Degani (Jerusalem, IL); Ami Eyal (Maccabim-Reut, IL)
Assignee: I Optima Ltd.
A61F9/00814A61B3/13A61F9/008A61F9/0026A61F9/00802A61F9/045A61F2009/00865A61F2009/00868A61F2009/00891A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,111,779
App. No.
15/280,174
Granted
Oct 30, 2018
Kind
B2
Abstract

An ophthalmic laser ablation system is described with various optional features, some especially suitable for non-penetrating filtration on an eye. In one example, focusing of an ablation laser uses a movable lens coupled to a pair of converging light sources, which converge at the focal distance of the lens. In another example, laser ablation settings are selected for optimal ablation and minimal amount of thermal damage of a layer of percolating scleral tissue.

Claims (6)

1. A method, comprising:

providing a laser scanner, wherein the laser scanner is configured to allow to control a direction of at least two converging beams that are generated from at least two light sources;

identifying a target ablating area of an eye overlying at least one of a Schlemm canal and a trabecular meshwork;

utilizing the laser scanner to control the direction of the at least two converging beams to ablate at least a portion of a scleral tissue overlying a percolation layer above one or both of the Schlemm canal and the trabecular meshwork in the target ablating area of the eye so as to achieve, without a full thickness penetration of the Schlemm's canal or the trabecular meshwork, a percolation of an aqueous humor of the eye to reduce an elevated intra-ocular pressure while causing a minimal thermal damage to the percolation layer and surrounding tissue.

2. The method of claim 1 , further comprising a step of applying to an area of scleral tissue ablated an amount of at least one material chosen from a group consisting of anti-inflammatory materials and anti-proliferation materials sufficient to reduce scarring.

3. The method of claim 1 , wherein the identified target ablating area includes a concave portion following an outer curvature of a limbus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2020
From: DEGANI, JOSHUA; EYAL, AMI
To: I OPTIMA LTD.
Reel/Frame 054369/0789 →
Continuity (4)
Continuation 13142803
Provisional Application 61202184 · Feb 4, 2009
Provisional Application 61193865 · Dec 31, 2008
Related Publication 20170014271A1 · Jan 19, 2017